109 related articles for article (PubMed ID: 26314485)
1. Vasoactive intestinal peptide represses activation of tumor-associated macrophages in gastric cancer via regulation of TNFα, IL-6, IL-12 and iNOS.
Chen L; Yuan W; Chen Z; Wu S; Ge J; Chen J; Chen Z
Int J Oncol; 2015 Oct; 47(4):1361-70. PubMed ID: 26314485
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
3. Effect of vasoactive intestinal peptide on gastric adenocarcinoma.
Li GH; Qian W; Song GQ; Hou XH
J Gastroenterol Hepatol; 2007 Aug; 22(8):1328-35. PubMed ID: 17559364
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of IFN-gamma-stimulated proinflammatory cytokines by vasoactive intestinal peptide (VIP) correlates with increased survival of Salmonella enterica serovar typhimurium phoP in murine macrophages.
Foster N; Hulme SD; Barrow PA
J Interferon Cytokine Res; 2005 Jan; 25(1):31-42. PubMed ID: 15684620
[TBL] [Abstract][Full Text] [Related]
5. Interaction of coagulation factors and tumor-associated macrophages mediates migration and invasion of gastric cancer.
Ma YY; He XJ; Wang HJ; Xia YJ; Wang SL; Ye ZY; Tao HQ
Cancer Sci; 2011 Feb; 102(2):336-42. PubMed ID: 21134074
[TBL] [Abstract][Full Text] [Related]
6. Role of tumor-associated macrophages in renal cell carcinoma.
Ikemoto S; Yoshida N; Narita K; Wada S; Kishimoto T; Sugimura K; Nakatani T
Oncol Rep; 2003; 10(6):1843-9. PubMed ID: 14534706
[TBL] [Abstract][Full Text] [Related]
7. Antisense knockdown of inducible nitric oxide synthase inhibits the relaxant effect of VIP in isolated smooth muscle cells of the mouse gastric fundus.
Dick JM; Van Molle W; Libert C; Lefebvre RA
Br J Pharmacol; 2001 Sep; 134(2):425-33. PubMed ID: 11564662
[TBL] [Abstract][Full Text] [Related]
8. Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells.
Wang M; Cai J; Huang F; Zhu M; Zhang Q; Yang T; Zhang X; Qian H; Xu W
Int J Mol Med; 2015 Feb; 35(2):367-75. PubMed ID: 25483835
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
[TBL] [Abstract][Full Text] [Related]
10. CCL5 secreted by tumor associated macrophages may be a new target in treatment of gastric cancer.
Ding H; Zhao L; Dai S; Li L; Wang F; Shan B
Biomed Pharmacother; 2016 Feb; 77():142-9. PubMed ID: 26796278
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Toll-like receptor 4 with vasoactive intestinal peptide attenuates liver ischemia-reperfusion injury.
Jiang W; Tang W; Geng Q; Xu X
Transplant Proc; 2011 Jun; 43(5):1462-7. PubMed ID: 21693218
[TBL] [Abstract][Full Text] [Related]
12. Lipid accumulation in macrophages confers protumorigenic polarization and immunity in gastric cancer.
Luo Q; Zheng N; Jiang L; Wang T; Zhang P; Liu Y; Zheng P; Wang W; Xie G; Chen L; Li D; Dong P; Yuan X; Shen L
Cancer Sci; 2020 Nov; 111(11):4000-4011. PubMed ID: 32798273
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
[TBL] [Abstract][Full Text] [Related]
14. Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host: Implication in antitumor activation of tumor-associated macrophages.
Vishvakarma NK; Singh SM
Immunol Lett; 2010 Nov; 134(1):83-92. PubMed ID: 20837061
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide synthase is induced in tumor promoter-sensitive, but not tumor promoter-resistant, JB6 mouse epidermal cells cocultured with interferon-gamma-stimulated RAW 264.7 cells: the role of tumor necrosis factor-alpha.
Murakami A; Kawabata K; Koshiba T; Gao G; Nakamura Y; Koshimizu K; Ohigashi H
Cancer Res; 2000 Nov; 60(22):6326-31. PubMed ID: 11103793
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.
Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Brunel N; Lescure B; Klein C; Fattal E; Behar-Cohen F; de Kozak Y
J Ocul Pharmacol Ther; 2009 Feb; 25(1):9-21. PubMed ID: 19232006
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated macrophage (TAM) infiltration in gastric cancer.
Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Okumura H; Matsumoto M; Miyazono F; Hokita S; Aikou T
Anticancer Res; 2003; 23(5A):4079-83. PubMed ID: 14666722
[TBL] [Abstract][Full Text] [Related]
18. VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression.
Delgado M; Sun W; Leceta J; Ganea D
J Immunol; 1999 Oct; 163(8):4213-23. PubMed ID: 10510358
[TBL] [Abstract][Full Text] [Related]
19. Interaction between pancreatic cancer cells and tumor-associated macrophages promotes the invasion of pancreatic cancer cells and the differentiation and migration of macrophages.
Meng F; Li C; Li W; Gao Z; Guo K; Song S
IUBMB Life; 2014 Dec; 66(12):835-46. PubMed ID: 25557640
[TBL] [Abstract][Full Text] [Related]
20. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity.
Whitmore MM; DeVeer MJ; Edling A; Oates RK; Simons B; Lindner D; Williams BR
Cancer Res; 2004 Aug; 64(16):5850-60. PubMed ID: 15313929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
